David Dintenfass - 10 Nov 2026 Form 4 Insider Report for HUMANA INC (HUM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Nov 2026, 14:30:56 UTC
Prior SEC filing
05 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
David Dintenfass
Filing notes and source

Key filing fact

David Dintenfass filed Form 4 for HUMANA INC (HUM) on 12 Nov 2026.

Key facts

  • This page summarizes David Dintenfass's Form 4 filing for HUMANA INC (HUM).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 12 Nov 2026, 14:30.

Change

  • Previous filing in this sequence was filed on 05 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002010288 Primary reporting owner

Dintenfass David

Relationship
President, Enterprise Growth
Address
HUMANA INC., 101 E. MAIN STREET, LOUISVILLE
Signature
David Dintenfass
Signature date
12 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM transaction

Humana Common

Gift

Transaction value
Shares
-230
Change %
-0.91%
Price
$0.000000*
Shares after
25,177
Date
10 Nov 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
51,389
Date
10 Nov 2026
Ownership
Direct
Underlying class
Humana Common
Underlying amount
51,389
Exercise price
$367.21
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Footnote F2

Includes 18,617 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

Footnote F3

Shares disposed of represent a gift/charitable donation, effective 11/10/26, in which no value was received in return.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .